At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Hyperbaric Oxygen Therapy (HBOT)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study of Short Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine in Patient With Diabetic Foot Ulcer Wagner 3-4
In Brief
A clinical study evaluating Hyperbaric Oxygen Therapy (HBOT) for Hyperbaric Oxygen Therapy and 2 related conditions. Completed, enrolled 30 participants.
Detailed Summary
The investigators want to evaluate the short duration HBOT can improve glycohemoglobin (HbA1c) levels, leukocyte count, and serum creatinine levels in patients with DFU (diabetic foot ulcer) Wagner 3-4.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartDec 2016
Primary CompletionMar 2017
First PostedAug 2018
TodayJul 2026
First PostedAug 6, 2018
Enrollment StartDec 27, 2016
Primary CompletionMar 31, 2017
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.9 years ago
Interventions
Hyperbaric Oxygen Therapy (HBOT)other
The investigators used 10 sessions of HBOT. One session of HBOT uses oxygen at 2.4 ATA for 90 minutes per day at multiplace hyperbaric chamber. This therapy is given five sessions in a week, so it takes two weeks.